Daclatasvir + asunaprevir versus sofosbuvir/ledipasvir for hepatitis C genotype 1 in Japanese patients: an indirect comparison

Journal of Comparative Effectiveness Research, 2016 05; 5(3): 273-279. e-pub ahead of print 2016/01/23

To compare daclatasvir + asunaprevir (DCV + ASV) versus sofosbuvir/ledipasvir (SOF/LDV) for hepatitis C virus genotype 1b in Japanese patients without NS5A polymorphisms at L31 and Y93H.

View abstract

Authors

Swallow E, Kelley C, Signorovitch J, Wygant G, McPhee F.